शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSELink Pharma Chem Ltd· Chemicals & PetrochemicalsHighNeutral
Announced Tue, 27 May, 2025 · 18:13 IST

Outcome of Board Meeting held on 27th May, 2025.

Revenue declinedNet loss reportedResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.5%Reaction day
₹35.90
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-2.8% vs market
Commodity Chemicals peers, median of 52sector-0.1%-2.3% vs sector

On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.5+0.3-2.8-0.1-2.3
Next day
-2.5+0.7-3.2-0.2-2.3
2d
+2.6+1.0+1.6-0.1+2.7
3d
-0.1+1.1-1.2-0.5+0.4
4d
+1.6+0.8+0.8-0.5+2.1
5d
+0.0+1.3-1.3-0.1+0.1
1w
-2.5+1.7-4.3-0.4-2.1
15d
+0.3+1.5-1.2-0.1+0.4
1m
+4.5+4.0+0.4+1.4+3.0
2m
+1.3+1.8-0.5-1.7+2.9
3m
-9.0-1.0-8.1-3.7-5.3
UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 52Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board approved audited financial results for the quarter and year ended March 31, 2025. Revenue from operations fell about 15% to Rs 2,543.34 lakhs (FY24: Rs 2,989.77 lakhs). The company reported a net loss of Rs 102.73 lakhs for FY25, though the loss narrowed from Rs 136.29 lakhs in FY24. Q4 FY25 revenue was Rs 644.66 lakhs with a loss of Rs 35.02 lakhs, against a profit of Rs 26 lakhs in Q4 FY24. EPS was negative Rs 2.31 (FY24: negative Rs 3.07). Operating cash flow improved sharply to Rs 268.59 lakhs from a negative Rs 2.80 lakhs last year. Statutory auditor CNK & Associates LLP issued an unmodified opinion. The Board also re-appointed Secretarial Auditor (Vijay Bhatt & Co.), Internal Auditor (Dipak Rajpara & Co.), and Cost Auditor (Y.S. Thakar & Co.) for FY26.

Likely market impact

Continued losses and a revenue decline are concerning for shareholders, but the narrower loss, improved operating cash flow, and clean audit offer some comfort. The stock may face pressure given the weak topline and persistent bottom-line losses.